The first iPad App from the CancerHelp Institute is our "Learning More About Chemotherapy." The App brings several import learning programs together for patients and those that care for them. The main feature is our "Listen and Learn" module based on the booklet Chemotherapy and You: Support for People with Cancer from the National Cancer Institute.
CancerHelp's iPad App: Learn More About Chemotherapy
The Listen and Learn program for Chemotherapy and You lets patient go at their own pace and engage with the content through interactive features such as dictionary term look up and Questions for Understanding. The Listen and Learn program also supports patients and caregivers with low energy, English as a Second Language patients, and persons with low literacy skills.
Sample menu item from the "Learning More About Chemotherapy" iPad App
The iPad makes it convenient for users to learn while receiving chemotherapy or in clinic waiting rooms. The iPad can be used stand-alone or on a rolling cart with extender arm for user comfort while learning.
The App can also include video of your facilities doctors or nurses encouraging patients to learn more. Health studies show that the more patients learn about their treatment, the better their health outcomes because they are able to anticipate and cope with things like side effects.
Two other important and easy-to-read resources include access to the NCI's Understanding Chemotherapy 4 page sheet and all of the Managing Chemotherapy Side Effects (18 topics in all) series.
Sample menu item for Managing Chemotherapy Side Effects from the "Learning More About Chemotherapy" iPad App
The CancerHelp Institute is also developing an iPad App for cancer patient education on Cancer Clinical Trials. The app will have an engaging "Listen and Learn" program of the NCI's Booklet "Taking Part in Cancer Treatment Research Studies."
Next up for our iPad App development are titles for Learning More about Breat Cancer and Learning More About Radiation Therapy. Each uses trusted content from the National Cancer Institute.